By Bansari Mayur Kamdar (Reuters) - Popular investor Cathie Woods is entering the European market with the acquisition of Rize ETF, but some investors ...
By Bansari Mayur Kamdar - Popular investor Cathie Woods is entering the European market with the acquisition of Rize ETF, but some investors are skeptical about the one-time pandemicLamborghinis on display in Point Pleasant Park | SaltWire - Popular investor Cathie Woods is entering the European market with the acquisition of Rize ETF, but some investors are skeptical about the one-time pandemic darling's foray into the region's nascent ETF market.
Shares of Ark's flagship fund, ARK Innovation, have gained 33% so far this year, after two straight years of sharp losses. "ARK now has a foot in the European door, but it still has work to do to persuade fund buyers they need exposure to their specialist, high-octane fund range."
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cathie Wood’s Ark Buys Rize ETF in Big Bet on European GrowthCathie Wood’s Ark Investment Management has acquired a fellow exchange-traded fund issuer in its biggest push yet into Europe’s nascent market for trend-driven investing.
Read more »
Cathie Wood Sees Revival of Thematic Investing When Fed Cuts RatesInvestors will flock to funds focusing on buzzy themes when the Federal Reserve cuts interest rates, according to Cathie Wood, who is doubling down on innovative investment strategies with a new acquisition.
Read more »
Britain must not damage financial sector resilience, says BoE's WoodsBy Huw Jones LONDON (Reuters) - Easing rules to boost the post-Brexit global competitiveness of Britain's financial sector can only be done while ...
Read more »
Bank of England's Woods says impairments among banks are risingMarket News
Read more »
European Commission authorises GSK's HIV prevention drug(Reuters) - The European Commission has authorised GSK's HIV-focused unit ViiV Healthcare's cabotegravir long-acting injectable and tablets, the ...
Read more »
European Commission authorises GSK's HIV prevention drug(Reuters) - The European Commission has authorised GSK's HIV-focused unit ViiV Healthcare's cabotegravir long-acting injectable and tablets, the ...
Read more »